Çakir, H. And EROĞLU, O. 2021. In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting.. Iranian journal of basic medical sciences , vol.24, no.11 , 1515-1522.

Çakir, H., & EROĞLU, O., (2021). In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting.. Iranian journal of basic medical sciences , vol.24, no.11, 1515-1522.

Çakir, HACER, And ONUR EROĞLU. "In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting.," Iranian journal of basic medical sciences , vol.24, no.11, 1515-1522, 2021

Çakir, HACER K. And EROĞLU, ONUR. "In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting.." Iranian journal of basic medical sciences , vol.24, no.11, pp.1515-1522, 2021

Çakir, H. And EROĞLU, O. (2021) . "In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting.." Iranian journal of basic medical sciences , vol.24, no.11, pp.1515-1522.

@article{article, author={HACER KAYA ÇAKIR And author={ONUR EROĞLU}, title={In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting.}, journal={Iranian journal of basic medical sciences}, year=2021, pages={1515-1522} }